INO-A002 / Inovio  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
INO-A002 / Inovio
NCT03831503: A Study of INO-A002 in Healthy Dengue Virus-naive Adults

Completed
1
30
US
INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG)
University of Pennsylvania, Inovio Pharmaceuticals
Healthy Volunteers
10/22
10/22

Download Options